Roswell Park Comprehensive Cancer Center and University of Rochester’s Wilmot Cancer Institute received a $2.08 million grant from NCI to research whether Black and white cancer patients respond differently to immune checkpoint inhibitors.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
